BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//UW Department of Psychiatry - ECPv6.16.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.psychiatry.wisc.edu
X-WR-CALDESC:Events for UW Department of Psychiatry
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20180311T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20181104T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20190310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20191103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20200308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20201101T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20210314T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20211107T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20200131T080000
DTEND;TZID=America/Chicago:20200131T090000
DTSTAMP:20260619T181358
CREATED:20191204T183546Z
LAST-MODIFIED:20200107T200235Z
UID:4202-1580457600-1580461200@www.psychiatry.wisc.edu
SUMMARY:Megan Moreno\, MD\, MSED\, MPH | UW Psychiatry Grand Rounds
DESCRIPTION:Social Media and Adolescent Mental Health\nMegan Moreno\, MD\, MSED\, MPH \nAcademic Division Chief of General Pediatrics and Adolescent Medicine Division\nVice Chair of Digital Health\nPrincipal Investigator\, SMAHRT\nDepartment of Pediatrics\nUniversity of Wisconsin-Madison \nLearning objectives: \n\nUnderstand the current state of the field regarding associations between social media and adolescent mental health\nLearn two measurement approaches in assessing social media use\nUnderstand proposed mechanisms for the relationship between social media and adolescent mental health\nLearn about several current national efforts to improve adolescent mental health and technology use\nConsider how to approach social media use with patients\n\n\nDr. Megan Moreno\, MD\, MSEd\, MPH is the principal investigator (PI) of the Social Media and Adolescent Health Research Team (SMAHRT). Her research team is within the Department of Pediatrics at the University of Wisconsin-Madison. Dr. Moreno is the Academic Division Chief of General Pediatrics and Adolescent Medicine Division\, and Vice Chair of Digital Health in the Department of Pediatrics. She is a Professor of Pediatrics and Adjunct Professor of Educational Psychology at the University of Wisconsin-Madison. \nDr. Moreno received her MD degree from George Washington University School of Medicine. She completed a residency in Pediatrics at the University of Wisconsin-Madison\, during that time she also completed a Masters Degree in Education. She completed a fellowship in Adolescent Medicine at the University of Washington\, during that time she also completed a Masters Degree in Public Health. \n  \n\n \nAccreditation Statement \nIn support of improving patient care\, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. \nCredit Designation Statement: \nThe University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. The University of Wisconsin–Madison ICEP\, as a member of the University Professional & Continuing Education Association (UPCEA)\, authorizes this program for 0.1 CEUs or 1.0 hour.
URL:https://www.psychiatry.wisc.edu/event/megan-moreno-md-msed-mph-uw-psychiatry-grand-rounds/
LOCATION:Webex
CATEGORIES:CME,Grand Rounds
ATTACH;FMTTYPE=image/png:https://www.psychiatry.wisc.edu/wp-content/uploads/2019/12/Dr.-Megan-Moreno-768x512.png
ORGANIZER;CN="Jennifer Noll":MAILTO:jnoll3@wisc.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20200115T120000
DTEND;TZID=America/Chicago:20200115T130000
DTSTAMP:20260619T181358
CREATED:20191009T172708Z
LAST-MODIFIED:20191220T200031Z
UID:4101-1579089600-1579093200@www.psychiatry.wisc.edu
SUMMARY:Educational Conference: Sarah Hackenmueller\, PhD - "Overview of toxicology and TDM testing at UW Health"
DESCRIPTION:Sarah Hackenmueller\, PhD \nTitle: Overview of toxicology and TDM testing at UW Health \nLocation:\n4th Floor Conference Room\nUW Behavioral Health & Recovery\n1102 South Park Street\nMadison\, WI 53715 \nLearning objectives: \nAt the conclusion of this activity\, participants will be able to: \n\nList the drugs that are primarily detected in urine drug screen assays.\nDiscuss differences between immunoassay and chromatography based methods of analysis.\nDetermine which specimen type\, urine or serum\, is most appropriate for different drug testing scenarios.\n\n\nAbout the Speaker:\n \nSarah Hackenmueller\, PhD \nAssistant Professor (CHS)\nDirector of Clinical Chemistry\nDepartment of Pathology and Laboratory Medicine\nUniversity of Wisconsin-Madison \nI received my PhD in the Department of Physiology and Pharmacology at Oregon Health and Science University and completed a clinical chemistry post-doctoral fellowship at the University of Utah and ARUP Laboratories in Salt Lake City prior to moving to Madison.  I have been the Director of Clinical Chemistry at UW since 2014 and Director of Toxicology since 2019. \n  \nhttps://pathology.wisc.edu/staff/hackenmueller-sarah/ \n\nAbout the Series: \nThe Educational Conference series is a series of lectures designed to provide clinically useful information to the practicing psychiatrist (faculty or trainee).  Every 1 to 2 months an intra- or extra-departmental speaker is invited to speak on a topic of interest selected by current faculty.  This educational series is open to the public and anyone is welcome to attend.  Continue Medical Education units (CME’s) are available to eligible attendees.
URL:https://www.psychiatry.wisc.edu/event/educational-conference-sarah-hackenmueller-phd-topic-toxicology/
LOCATION:Group Room A (4th Floor) | 1102 S Park St | UW Behavioral Health & Recovery\, 1102 S Park Street\, Suite 400\, Madison\, Wisconsin\, 53715
CATEGORIES:CME,Educational Conference (Park Street)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20191218T120000
DTEND;TZID=America/Chicago:20191218T130000
DTSTAMP:20260619T181358
CREATED:20191004T185628Z
LAST-MODIFIED:20191004T191540Z
UID:4073-1576670400-1576674000@www.psychiatry.wisc.edu
SUMMARY:Educational Conference: Ron Diamond\, MD - "Long-Acting Injectables"
DESCRIPTION:Long-Acting Injectables \nRon Diamond\, MD  \nLocation:\n4th Floor Conference Room\nUW Behavioral Health & Recovery\n1102 South Park Street\nMadison\, WI 53715 \n\nAbout the Speaker: \nFor more than 40 years\, Dr. Diamond has been involved in the community-based treatment of persons with severe and persistent mental illness.  He has taught and written on issues of staff training\, ethics\, staff roles\, decreasing coercion\, medication compliance\, psychiatric administration and system design. For more than three decades\, he has been interested in how to integrate concepts of recovery and cultural competence into day-to-day clinical practice.  His psychopharmacology book\, “ Instant Psychopharmacology” was written for non-medical clinicians\, consumers and family members.  The third edition of this was published in 2009.  In keeping with all of his work\, drafts of this book were reviewed by consumers\, as was his previous book\, “Treatment collaboration\, improving the therapist\, prescriber\, client relationship” published in 2007.  His newest book\, The Medication Question:  Weighing Your Mental Health Treatment Options for Patients and Their Families was published in 2011. \nHe retired from Journey Mental Health in Feb 2013 after 35 years\, first as staff psychiatrist and then Medical Director.   He retired from the UW Department of Psychiatry Jan 2018 after 39 years on the faculty. \nSpecialties \n\nCommunity Psychiatry\nEmergency Psychiatry\nSchizophrenia\nPsychopharmacology\nPrimary Care Behavioral Care Integration\n\n\nAbout the Series: \nThe Educational Conference series is a series of lectures designed to provide clinically useful information to the practicing psychiatrist (faculty or trainee).  Every 1 to 2 months an intra- or extra-departmental speaker is invited to speak on a topic of interest selected by current faculty.  This educational series is open to the public and anyone is welcome to attend.  Continue Medical Education units (CME’s) are available to eligible attendees.
URL:https://www.psychiatry.wisc.edu/event/educational-conference-ron-diamond-md-long-acting-injectables/
LOCATION:Group Room A (4th Floor) | 1102 S Park St | UW Behavioral Health & Recovery\, 1102 S Park Street\, Suite 400\, Madison\, Wisconsin\, 53715
CATEGORIES:CME,Educational Conference (Park Street)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20191121T000000
DTEND;TZID=America/Chicago:20191121T000000
DTSTAMP:20260619T181358
CREATED:20191121T200446Z
LAST-MODIFIED:20191121T200507Z
UID:4184-1574294400-1574294400@www.psychiatry.wisc.edu
SUMMARY:Women’s Health Case Conference - Zachary Stowe\, MD
DESCRIPTION:Women’s Mental Health covers a wide range of situations (e.g. psychiatric illness\, trauma\, body image\, peripartum/reproductive health/loss\, pelvic pain\, etc.).
URL:https://www.psychiatry.wisc.edu/event/womens-health-case-conference-zachary-stowe-md/
CATEGORIES:CME,Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20191115T120000
DTEND;TZID=America/Chicago:20191115T131500
DTSTAMP:20260619T181358
CREATED:20190215T214815Z
LAST-MODIFIED:20191009T190329Z
UID:3517-1573819200-1573823700@www.psychiatry.wisc.edu
SUMMARY:Karen J. Parker\, PhD | UW Psychiatry Grand Rounds
DESCRIPTION:Advances in Detecting and Treating Autism\nKaren J. Parker\, PhD\nAssociate Professor\nDirector\, Social Neurosciences Research Program\nDepartment of Psychiatry and Behavioral Sciences\nStanford University School of Medicine \nReading List: \n\nCerebrospinal Fluid Vasopressin and Symptom Severity in Children with Autism\nA randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism\nArginine vasopressin in cerebrospinal fluid is a marker of sociality in nonhuman primates\nEarly Predictors of Impaired Social Functioning in Male Rhesus Macaques\n\n\nDr. Parker is an Associate Professor of Psychiatry and Behavioral Sciences at Stanford University where she directs the Social Neurosciences Research Program. Dr. Parker’s research expertise is the biology of social functioning\, with a particular interest in oxytocin and vasopressin signaling pathways. Her preclinical research program focuses on developing novel animal models of social impairments; her clinical research program encompasses biomarker discovery and therapeutic testing in patients with autism and other brain disorders. \nDr. Parker received her undergraduate and graduate degrees from the University of Michigan and completed postdoctoral training at Stanford University. Dr. Parker joined the Stanford faculty in 2007. She is an Affiliate Scientist at the California National Primate Research Center\, a Member of the American College of Neuropsychopharmacology\, and a Kavli Fellow of the US National Academy of Sciences. Dr. Parker’s research program has been supported by multiple funding agencies including the NIH\, Simons Foundation\, and NARSAD. Dr. Parker serves on the Editorial Board of Psychoneuroendocrinology\, and on various national (e.g.\, NIH and NSF) and international (e.g.\, Medical Research Council) grant review committees and scientific panels. \nDr. Parker was born in Boulder\, CO and grew up in suburban Chicago\, IL. She lives in the San Francisco Bay Area with her husband (a high-tech executive)\, three children\, and an Australian shepherd. \n  \n\n \nAccreditation Statement \nIn support of improving patient care\, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. \nCredit Designation Statement: \nThe University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. The University of Wisconsin–Madison ICEP\, as a member of the University Professional & Continuing Education Association (UPCEA)\, authorizes this program for 0.1 CEUs or 1.0 hour.
URL:https://www.psychiatry.wisc.edu/event/karen-j-parker-phd-uw-psychiatry-grand-rounds/
LOCATION:Webex
CATEGORIES:CME,Grand Rounds
ORGANIZER;CN="Jennifer Noll":MAILTO:jnoll3@wisc.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20191016T120000
DTEND;TZID=America/Chicago:20191016T130000
DTSTAMP:20260619T181358
CREATED:20190215T231416Z
LAST-MODIFIED:20191008T202258Z
UID:3544-1571227200-1571230800@www.psychiatry.wisc.edu
SUMMARY:Educational Conference: Laura Buyan Dent\, MD - "An Update on Tardive Dyskinesia"
DESCRIPTION:An Update on Tardive Dyskinesia \nLaura Buyan Dent\, MD \nLearning Objectives: \n\nIdentify various forms of tardive dyskinesia\nDescribe rationale to prevent development of tardive dyskinesia\nIdentify treatment options\, including recently available medications\n\nLocation:\n4th Floor Conference Room\nUW Behavioral Health & Recovery\n1102 South Park Street\nMadison\, WI 53715 \n\nAbout the Speaker:\n\nDr. Laura Buyan Dent is a neurologist in the Movement Disorders Program. Dr. Buyan Dent’s main focus is the care of patients with Parkinson’s disease\, Huntington’s disease\, essential tremor\, dystonia\, multiple systems atrophy\, progressive supranuclear palsy and other movement disorders. With state-of-the-art pharmaceutical treatments\, botulinum toxin injections and surgical management options\, Dr. Buyan Dent helps patients with a unique program that suits their particular conditions. \nAs part of the Performing Arts Medicine Program\, she is dedicated to the care of artists with neurologic conditions such as tremors\, dystonias and ataxias\, that may interfere with performance and movement. She also helps with performance-related overuse conditions or injuries that result in focal dystonia\, nerve injuries\, weakness\, tremors and coordination difficulties. \nhttps://www.uwhealth.org/findadoctor/profile/laura-j-buyan-dent-md-phd/5637 \n\nAbout the Series: \nThe Educational Conference series is a series of lectures designed to provide clinically useful information to the practicing psychiatrist (faculty or trainee).  Every 1 to 2 months an intra- or extra-departmental speaker is invited to speak on a topic of interest selected by current faculty.  This educational series is open to the public and anyone is welcome to attend.  Continue Medical Education units (CME’s) are available to eligible attendees.
URL:https://www.psychiatry.wisc.edu/event/educational-conference-laura-buyan-dent-md-topic-tardive-dyskinesia/
LOCATION:Group Room A (4th Floor) | 1102 S Park St | UW Behavioral Health & Recovery\, 1102 S Park Street\, Suite 400\, Madison\, Wisconsin\, 53715
CATEGORIES:CME,Educational Conference (Park Street)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20191011T073000
DTEND;TZID=America/Chicago:20191012T120000
DTSTAMP:20260619T181358
CREATED:20190930T214417Z
LAST-MODIFIED:20190930T214417Z
UID:4065-1570779000-1570881600@www.psychiatry.wisc.edu
SUMMARY:7th Annual Update and Advances in Psychiatry Conference
DESCRIPTION:REGISTER VIA ICEP PORTAL:\nhttps://ce.icep.wisc.edu/2019-Annual-Update#group-tabs-node-course-default6 \n\nAvailable credit:\n\n\n\n\n9.00 AMA PRA Category 1 Credit™\n9.00 University of Wisconsin–Madison Continuing Education Hours\n\n\n\n\nSTATEMENT OF NEED\nThis activity is being held in response to mental health professionals’ previous conference evaluations and the need for ongoing continuing medical education for clinicians in the area of psychiatry. \nELEMENTS OF COMPETENCE\nThis CME activity has been designed to change learner competence and focuses on the American Board of Medical Specialties’ areas of medical knowledge and patient care and procedural skills. \n\n\n\n\nTARGET AUDIENCE\n\n\n\nThis educational activity has been designed to meet the needs of clinicians and other health care professionals who are looking to enhance their knowledge and skills for the care of their patients with mental health issues. \n\n\n\n\n\nLEARNING OBJECTIVES\n\n\n\nAt the conclusion of this educational activity\, participants should be able to: \n\nDescribe the data supporting efficacy and risks associated with transcranial magnetic stimulation in the treatment of major depressive disorder\nDevelop a plan to address substances use disorders in their patients who are children or adolescents\nManage the challenges associated with caring for patients with personality disorders\nSummarize how to balance working with children and their parents in the context of divorce\nList the most recently developed and discovered drugs of abuse\, and their psychiatric sequelae\nDevelop a plan to screen for\, diagnose\, and treat bipolar disorder in their older adult patients\nDevelop and implement a treatment plan for their patients with obsessive-compulsive disorder\nAppreciate the clinical and research links between substance use disorders and eating disorders\nDescribe the steps that health care providers can take to promote wellness within their institutions\n\n\n\n\n\n  \n\n\n\n\nFRIDAY\, OCTOBER 11\n\n\n7:15\nRegistration and Continental Breakfast\n\n\n8:00\nWelcome\nNed Kalin\, MD & Art Walaszek\, MD\n\n\n8:45\nRole of TMS in the Treatment of Major Depressive Disorder\nLinda L. Carpenter\, MD\n\n\n9:45\nQ & A\nModerator: Ned Kalin\, MD\n\n\n10:15\nRefreshment Break\n\n\n10:30\nAn Update on the Treatment of Substance Use Disorders in Adolescents\nJustine W. Welsh\, MD\n\n\n11:30\nQ & A\nModerator: Ned Kalin\, MD\n\n\n12:00\nLunch\n\n\n1:00\nBreakout Sessions & Case Discussions\n1) Strategies for Caring for Patients with Personality Disorders – Erri Hewitt\, PhD\n2) Providing Mental Health Care to Children with Divorced Parents – Jason Horowitz\, PhD\n3) New Drugs the Kids are Using These Days – Jennifer McDonald\, MD\n4) Recognizing and Treating Bipolar Disorder in Older Adults – Eileen Ahearn\, MD\n\n\n2:30\nRefreshment Break\n\n\n2:45\nIn Memoriam – James W. “Jeff” Jefferson\nJohn H. Greist\, MD; Ned Kalin\, MD; & Art Walaszek\, MD\n\n\n3:00\nInaugural James W. Jefferson Lecture\nOptimal Treatment of Obsessive-Compulsive Disorder\nJohn H. Greist\, MD\n\n\n4:00\nQ & A\nModerator: Ned Kalin\, MD\n\n\n4:30\nAdjourn\n\n\n\n\n\n\n\nSATURDAY\, OCTOBER 12\n\n\n7:45\nRegistration and Continental Breakfast\n\n\n8:25\nIntroduction\nNed Kalin\, MD & Art Walaszek\, MD\n\n\n8:30\nMy Career in Translational Addiction Research: From Opioids\, to Cocaine\, to Food\nMark S. Gold\, MD\n\n\n9:30\nQ & A\nModerator: Art Walaszek\, MD\n\n\n10:00\nRefreshment Break\n\n\n10:15\nThe Long Game: Stories of Our Lives in Medicine\nHelping students\, trainees and physicians create and sustain satisfying careers\nJoan M. Anzia\, MD\n\n\n11:15\nQ & A\nModerator: Art Walaszek\, MD\n\n\n11:45\nAdjourn
URL:https://www.psychiatry.wisc.edu/event/7th-annual-update-and-advances-in-psychiatry-conference/
LOCATION:Monona Terrace\, 1 John Nolen Dr\, Madison\, WI\, 53703\, United States
CATEGORIES:CME
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20190920T120000
DTEND;TZID=America/Chicago:20190920T130000
DTSTAMP:20260619T181358
CREATED:20190416T154030Z
LAST-MODIFIED:20190712T160850Z
UID:3624-1568980800-1568984400@www.psychiatry.wisc.edu
SUMMARY:Charles B. Nemeroff\, MD\, PhD | UW Psychiatry Grand Rounds
DESCRIPTION:Prediction of Disease Vulnerability and Treatment Response in Mood Disorders and PTSD: Personalized Medicine in Psychiatry \n\nFRIDAY SEPT 13 | 12:00pm\nWisPIC Commons Room 1616\n6001 Research Park Blvd \nCharles B. Nemeroff\, MD\, PhD\nChair and Professor of Psychiatry\nDirector\, Institute for Early Childhood Adversity Research\nUniversity of Texas at Austin – Dell Medical School \nLearning Objectives \n\nTo understand the principles of personalized medicine as applied to mood and anxiety disorders.\nTo understand the role of Genome Wide Association Studies (GWAS)\, candidate gene approaches\, transcriptomics\, epigenetics\, and proteomics in predicting disease treatment response in mood and anxiety disorders.\nTo understand the potential for functional brain imaging for predicting treatment response in mood and anxiety disorders.\nTo understand the role of gene-environment interactions\, particularly early life trauma\, in predicting treatment response in mood disorders.\n\n\nCharles B. Nemeroff\, MD\, PhD\, is a Professor of Psychiatry and Acting Chair of the Department of Psychiatry. He is also Associate Chair of Research\, and the Director of the Institute for of Early Life Adversity Research at Dell Medical School at the University of Texas at Austin. \nHe received his MD and PhD (Neurobiology) degrees from the University of North Carolina UNC) School of Medicine in Chapel Hill\, North Carolina. After psychiatry residency training at UNC and Duke University\, he held faculty positions at Duke University and was Chair of the Department of Psychiatry and Behavioral Sciences at Emory University for 18 years before relocating to the University of Miami in 2009. \nHe has served as President of the American College of Psychiatrists (ACP) and the American College of Neuropsychopharmacology (ACNP) and sits on the Scientific Advisory Board and Board of Directors of the American Foundation for Suicide Prevention (AFSP) and the Anxiety and Depression Association of America \n  \nHe has received a number of research and education awards including the Kempf Award in Psychobiology\, the Samuel Hibbs Award\, Research Mentoring Award\,Judson Marmot Award and the Vestermark Award from the American Psychiatric Association (APA)\, the Mood Disorders Award\, Bowis Award and Dean Award from the ACP and the Julius Axelrod Award for mentoring from the ACNP. He was elected to the Institute of Medicine (now the National Academy of Medicine) of the National Academy of Sciences in 2002. \nHe has been named Alumnus of the Year from the University of North Carolina (UNC) and from the UNC Medical School. He received the Doctorate Honoris Causa from Maimonides University in Buenos Aires in 2015. \nHis research has focused on the pathophysiology of mood and anxiety disorders with a focus on the role of child abuse and neglect as a major risk factor. He has also focused on the role of mood disorders as a risk factor for major medical disorders including heart disease\, diabetes and cancer. He has published more than 1100 research reports and reviews. \nHe has served on the Mental Health Advisory Council of NIMH and the Biomedical Research Council for NASA. He is the co-editor in chief (with Alan F. Schatzberg\, MD.) of the Textbook of Psychopharmacology\, published by the APA Press\, now in its Fifth Edition. \nHis research is currently supported by grants from the NIH.
URL:https://www.psychiatry.wisc.edu/event/grand-rounds-greenfield-speaker/
LOCATION:Webex
CATEGORIES:CME,Grand Rounds
ORGANIZER;CN="Jennifer Noll":MAILTO:jnoll3@wisc.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20190912T170000
DTEND;TZID=America/Chicago:20190912T190000
DTSTAMP:20260619T181358
CREATED:20190416T153918Z
LAST-MODIFIED:20190904T191128Z
UID:3622-1568307600-1568314800@www.psychiatry.wisc.edu
SUMMARY:Greenfield Memorial Lecture: Progress in Suicide Prevention | Charles B. Nemeroff\, MD\, PhD
DESCRIPTION:Progress in Suicide Prevention\nTHURSDAY\, SEPTEMBER 12\, 2019\n5:30 – 7:00PM\nWisconsin Psychiatric Institute and Clinic\n6001 Research Park Boulevard\, Room 1616\n* Light refreshments will be served * \nCharles B. Nemeroff\, MD\, PhD\nProfessor and Acting Chair\nDepartment of Psychiatry\nAssociate Chair for Research\nDirector\, Institute of Early Life Adversity Research\nDell Medical School\, The University of Texas at Austin \n \nSuicide is the 10th leading cause of death in the United States\, the only one of the top ten that is increasing in number year after year. This year there will likely be 50\,000 suicides in the United States (130 per day) and in addition approximately 20\,000 of the 70\,000 opiate overdose deaths each year are classified as suicides. It is the second leading cause of death in the 15-34 year age group. In spite of many public health and education efforts in the past decade\, suicide rates have continued to climb. Research on risk factors for suicide have been informative.  Men are at significantly greater risk for suicide than women. In addition other risk factors that have been clearly documented are a past diagnosis of depression or related psychiatric disorders\,  history of childhood maltreatment including bullying\, family history of suicide (underlying the genetic component of risk)\, alcohol and substance abuse\, as well as more recent life stressors such as loss of job\, a recent serious medical diagnosis\, imminent divorce and recent trauma. The reduction of available psychiatric inpatient beds is also associated with the year over year increase nationally. There is considerable evidence for an underlying neurobiological basis for suicidality including increased inflammation\, decreased activity of serotonergic circuits in the brain and increase activity of the major mammalian stress system\, the pituitary-adrenal axis. Certain medications including lithium and clozapine are known to reduce suicide as are  certain forms of cognitive-behavioral therapy (CBT). Finally providing obstacles to means of suicide has been shown to be effective in reducing suicide rates. \n  \n\nCharles B. Nemeroff\, MD\, PhD\, is a Professor of Psychiatry and Acting Chair of the Department of Psychiatry. He is also Associate Chair of Research\, and the Director of the Institute for of Early Life Adversity Research at Dell Medical School at the University of Texas at Austin. \nHe received his MD and PhD (Neurobiology) degrees from the University of North Carolina UNC) School of Medicine in Chapel Hill\, North Carolina. After psychiatry residency training at UNC and Duke University\, he held faculty positions at Duke University and was Chair of the Department of Psychiatry and Behavioral Sciences at Emory University for 18 years before relocating to the University of Miami in 2009. \nHe has served as President of the American College of Psychiatrists (ACP) and the American College of Neuropsychopharmacology (ACNP) and sits on the Scientific Advisory Board and Board of Directors of the American Foundation for Suicide Prevention (AFSP) and the Anxiety and Depression Association of America (ADAA). \nHe has received a number of research and education awards including the Kempf Award in Psychobiology\, the Samuel Hibbs Award\, Research Mentoring Award\,Judson Marmot Award and the Vestermark Award from the American Psychiatric Association (APA)\, the Mood Disorders Award\, Bowis Award and Dean Award from the ACP and the Julius Axelrod Award for mentoring from the ACNP. He was elected to the Institute of Medicine (now the National Academy of Medicine) of the National Academy of Sciences in 2002. \nHe has been named Alumnus of the Year from the University of North Carolina (UNC) and from the UNC Medical School. He received the Doctorate Honoris Causa from Maimonides University in Buenos Aires in 2015. \nHis research has focused on the pathophysiology of mood and anxiety disorders with a focus on the role of child abuse and neglect as a major risk factor. He has also focused on the role of mood disorders as a risk factor for major medical disorders including heart disease\, diabetes and cancer. He has published more than 1100 research reports and reviews. \nHe has served on the Mental Health Advisory Council of NIMH and the Biomedical Research Council for NASA. He is the co-editor in chief (with Alan F. Schatzberg\, MD.) of the Textbook of Psychopharmacology\, published by the APA Press\, now in its Fifth Edition. \nHis research is currently supported by grants from the NIH. \n\nAdditional Talk: \nFriday\, Sept 13 – 12:00pm | WisPIC Commons Room\nPsychiatry Grand Rounds \nPrediction of Disease Vulnerability and Treatment Response in Mood Disorders and PTSD: Personalized Medicine in Psychiatry \n \n\n  \nReading List: \n1. The Holy Grail of Psychiatry (2015) 81-89\n2. Understanding Depression – Contemporary Issues (2017) 21\, 245-261\n3. Psychosomatic Medicine (2014) 76\, 445-451
URL:https://www.psychiatry.wisc.edu/event/greenfield-memorial-lecture-2/
LOCATION:Webex
CATEGORIES:CME
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20190823T120000
DTEND;TZID=America/Chicago:20190823T131500
DTSTAMP:20260619T181358
CREATED:20190215T214254Z
LAST-MODIFIED:20190220T215220Z
UID:3515-1566561600-1566566100@www.psychiatry.wisc.edu
SUMMARY:Heather Abercrombie\, PhD | UW Psychiatry Grand Rounds
DESCRIPTION:Neurocognitive Sensitivity to Cortisol in Depression\n  \nHeather C. Abercrombie\, Ph.D.\nAssociate Professor (CHS)\nUniversity of Wisconsin-Madison\nSchool of Medicine and Public Health\nDepartment of Psychiatry \n\nMany individuals with depression show “glucocorticoid resistance\,” which reflects systemic and cellular insensitivity to the stress-related hormone cortisol.  However\, the neural and psychological relevance of glucocorticoid resistance is unknown. This is a huge gap in our knowledge\, because basic research shows that cortisol has potent yet variable effects on psychological function. Our research addresses this knowledge gap\, and we have shown that glucocorticoid resistance is related to negatively biased emotional memory and related neural circuitry. Importantly\, we have also shown that cortisol augmentation ameliorates negative memory bias in depression\, particularly in glucocorticoid resistant individuals. Taken together\, these findings suggest that glucocorticoid resistance is related to core psychological features of depression\, and that boosting cortisol signal may be psychologically beneficial in glucocorticoid resistant individuals with depression. \n  \nLearning objectives: \n\nDebunk popular notions of cortisol as unequivocally harmful\nUnderstand the relation between cortisol and psychological functions relevant to depression\nUnderstand that cortisol augmentation may be beneficial in depression\n\n\n \nAccreditation Statement \nIn support of improving patient care\, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. \nCredit Designation Statement: \nThe University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. The University of Wisconsin–Madison ICEP\, as a member of the University Professional & Continuing Education Association (UPCEA)\, authorizes this program for 0.1 CEUs or 1.0 hour.
URL:https://www.psychiatry.wisc.edu/event/heather-abercrombie-phd-uw-psychiatry-grand-rounds/
LOCATION:Webex
CATEGORIES:CME,Grand Rounds
ORGANIZER;CN="Jennifer Noll":MAILTO:jnoll3@wisc.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20190628T120000
DTEND;TZID=America/Chicago:20190628T131500
DTSTAMP:20260619T181358
CREATED:20190215T213540Z
LAST-MODIFIED:20190219T155141Z
UID:3511-1561723200-1561727700@www.psychiatry.wisc.edu
SUMMARY:Anna Ratzliff\, MD\, PhD | UW Psychiatry Grand Rounds
DESCRIPTION:Implementing Collaborative Care: Translation from Research to Real World\nAnna Ratzliff\, MD\, PhD\nAssociate Professor\nDepression Therapy Research Endowed Professorship\nDirector\, AIMS Center\nDirector\, UW Integrated Care Training Program \n  \nLearning Objectives:\n1)      List common barriers and facilitators to collaborative care implementation.\n2)      Describe five phases to implementation of collaborative care.\n3)      Name common factors influencing the sustainability of collaborative care. \nThis lecture will provide a brief overview of the collaborative care model (CoCM) and review current thinking about implementation of this approach to deliver mental health treatment in primary care settings.  An approach to the five phase of implementation will be discussed including common barriers and facilitators. \n\nDr. Anna Ratzliff is a national expert on collaborative care and specifically\, on training teams to implement and deliver mental health treatment in primary care settings. Her passion for translating complex research ideas into practical real-world applications began when she received her MD and PhD in Anatomy and Neurobiology as part of the Medical Scientist Training Program at the University of California at Irvine.  She currently is an Associate Professor in the Department of Psychiatry and Behavioral Sciences at the University of Washington where she has developed expertise in suicide prevention training\, mental health workforce development\, adult learning best practices\, and mentorship. Dr. Ratzliff is the Director of the AIMS Center (Advancing Integrated Mental Health Solutions)\, is the Director of the UW Integrated Care Training Program for residents and fellows\, and leads a national collaborative care training program for the American Psychiatric Association’s Transforming Clinical Practices Initiative grant. For more information on collaborative care please visit the AIMS Center Website (aims.uw.edu)\, the UW Integrated Care Training Program (ictp.uw.edu). \n\n \nAccreditation Statement \nIn support of improving patient care\, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. \nCredit Designation Statement: \nThe University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. The University of Wisconsin–Madison ICEP\, as a member of the University Professional & Continuing Education Association (UPCEA)\, authorizes this program for 0.1 CEUs or 1.0 hour.
URL:https://www.psychiatry.wisc.edu/event/anna-ratzliff-md-phd-uw-psychiatry-grand-rounds/
LOCATION:Webex
CATEGORIES:CME,Grand Rounds
ATTACH;FMTTYPE=image/jpeg:https://www.psychiatry.wisc.edu/wp-content/uploads/2019/02/Anna-Ratzliff-2018.jpg
ORGANIZER;CN="Jennifer Noll":MAILTO:jnoll3@wisc.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20190619T120000
DTEND;TZID=America/Chicago:20190619T130000
DTSTAMP:20260619T181358
CREATED:20190215T231216Z
LAST-MODIFIED:20190215T231216Z
UID:3542-1560945600-1560949200@www.psychiatry.wisc.edu
SUMMARY:Educational Conference: Steve Garlow\, MD [Topic: Transcranial Magnetic Stimulation]
DESCRIPTION:6/19/19\nSteve Garlow\, MD \nTopic: TMS – Transcranial Magnetic Stimulation\nTitle: TBD \n\nThe Educational Conference series is a series of lectures designed to provide clinically useful information to the practicing psychiatrist (faculty or trainee).  Every 1 to 2 months an intra- or extra-departmental speaker is invited to speak on a topic of interest selected by current faculty.  This educational series is open to the public and anyone is welcome to attend.  Continue Medical Education units (CME’s) are available to eligible attendees. \nLocation:\nGroup Room A\nUW Behavioral Health & Recovery\n1102 South Park Street\nMadison\, WI 53715
URL:https://www.psychiatry.wisc.edu/event/educational-conference-steve-garlow-md-topic-transcranial-magnetic-stimulation/
LOCATION:Group Room A (4th Floor) | 1102 S Park St | UW Behavioral Health & Recovery\, 1102 S Park Street\, Suite 400\, Madison\, Wisconsin\, 53715
CATEGORIES:CME,Educational Conference (Park Street)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20190419T120000
DTEND;TZID=America/Chicago:20190419T131500
DTSTAMP:20260619T181358
CREATED:20181120T184303Z
LAST-MODIFIED:20190228T210031Z
UID:3397-1555675200-1555679700@www.psychiatry.wisc.edu
SUMMARY:Boris Birmaher\, MD | UW Psychiatry Grand Rounds
DESCRIPTION:*** Part of the Briskey Family Bipolar Lecture Series*** \nPredicting the Development of Bipolar Disorder and Mood Recurrences –\nToward Personalized Psychiatry\nBoris Birmaher\, MD\nEndowed Chair in Early Onset Bipolar Disease and Professor of Psychiatry\nDirector\, Child and Adolescent Bipolar Spectrum Services\nCo-Director\, Psychiatry Research Pathway Program\nUniversity of Pittsburgh \nLearning objectives: \n\nTo describe the prodromal symptoms of bipolar disorder\nTo describe the course and outcome of bipolar disorder in youth and the factors associated with increases risk for recurrences\nTo describe the use of “risk calculators” to predict “personalized” risk to develop bipolar disorder as well as the risk of recurrences.\n\n\nDr. Birmaher is the Endowed Chair in Early Onset Bipolar Disease and Professor of Psychiatry at the University of Pittsburgh\, School of Medicine and serves as the Co-Director of the Psychiatry Research Pathway program and the Director of the Child and Adolescent Bipolar Spectrum Services.  He received his medical degree from Valle University in Cali\, Colombia; completed training in general psychiatry at the Hebrew University in Jerusalem\, Israel\, and child psychiatry at Columbia University\, New York. \nDr Birmaher is a leader in the study and treatment of pediatric mood and anxiety disorders. In addition\, his research has concentrated in describing the predictors\, risk factors\, course and treatment of childhood-onset bipolar disorder.  Throughout his career\, he has served as the Principal\, Co-Principal or co-investigator for over 25 federally-sponsored research grants and projects.  He has authored or co-authored more than 430 publications\, numerous book chapters as well as his own book\, New Hope for Children and Teens with Bipolar Disorder.  Dr. Birmaher has been the recipient of numerous awards over the years including the Colvin Prize for Outstanding Achievement in Mood Disorders Research in 2013 and the Ittleson Award for Research in Child and Adolescent Psychiatry in 2014.  In 2018\, he received the Gerald L Klerman Senior Investigator Award and the Lifelong Fellow Award from the American Psychiatric Association. For four years and until 10/2018 he was the Program Chair of the American Academy of Child and Adolescent Psychiatry and recently was named Counselor-At-Large of the same association. Through his research\, clinical and mentoring activities\, Dr. Birmaher has increased our understanding of the risk factors for mood and anxiety disorders\, developed and implemented innovative treatments to improve the lives of patients and their families\, and trained the next generation of educators\, clinicians and researchers. \n\n \nAccreditation Statement \nIn support of improving patient care\, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. \nCredit Designation Statement: \nThe University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. The University of Wisconsin–Madison ICEP\, as a member of the University Professional & Continuing Education Association (UPCEA)\, authorizes this program for 0.1 CEUs or 1.0 hour. \n 
URL:https://www.psychiatry.wisc.edu/event/boris-birmaher-md-uw-psychiatry-grand-rounds/
LOCATION:Webex
CATEGORIES:CME,Educational Conference (Park Street),Grand Rounds
ATTACH;FMTTYPE=image/jpeg:https://www.psychiatry.wisc.edu/wp-content/uploads/2018/11/Boris2017-1.jpg
ORGANIZER;CN="Jennifer Noll":MAILTO:jnoll3@wisc.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20190308T120000
DTEND;TZID=America/Chicago:20190308T131500
DTSTAMP:20260619T181358
CREATED:20190215T212132Z
LAST-MODIFIED:20190220T215057Z
UID:3501-1552046400-1552050900@www.psychiatry.wisc.edu
SUMMARY:Conor Liston\, MD\, PhD | UW Psychiatry Grand Rounds
DESCRIPTION:Neuroimaging Biomarkers for Diagnosing Neurophysiological Subtypes of Depression and Predicting Treatment Response\n  \nConor Liston\, MD\, PhD\nAssistant Professor of Neuroscience\nBrain and Mind Research Institute\nand Department of Psychiatry\nWeill Cornell Medicine \n\nConor Liston\, MD\, PhD is an Associate Professor of Neuroscience and Psychiatry in the Feil Family Brain and Mind Research Institute and the Department of Psychiatry at Weill Cornell Medicine. The long-term goals of his research program are to define mechanisms by which prefrontal cortical brain circuits support learning\, memory\, and motivation\, and to understand how these functions are disrupted in depression\, addictions\, and other stress-related psychiatric disorders. To this end\, experiments in his lab integrate optogenetic tools and genetically encoded calcium indicators with two-photon imaging and functional MRI\, and his team is actively developing new methods for quantifying prefrontal cortical microcircuit dynamics in genetically defined neuronal subtypes. They are also developing novel neuroimaging tools for informing psychiatric diagnosis in human populations and predicting treatment response to transcranial magnetic stimulation (TMS) and other neurostimulatory antidepressant interventions. \nDr. Liston graduated summa cum laude from Harvard College in 1998\, and received his PhD and MD from The Rockefeller University and Weill Cornell Medicine in 2007 and 2008\, respectively\, where he was supported by a Paul and Daisy Soros Fellowship for New Americans. He subsequently completed his residency in psychiatry at New York–Presbyterian Hospital and postdoctoral training at Stanford University. He returned to Weill Cornell as an Assistant Professor in 2014. His research has been recognized with awards from the Klingenstein-Simons Foundation Fund\, the Rita Allen Foundation\, the Dana Foundation\, the Doris Duke Charitable Foundation\, and the One Mind Institute. Dr. Liston is also a clinically active psychiatrist specializing in the management of treatment-resistant mood disorders. \n  \n\n \nAccreditation Statement \nIn support of improving patient care\, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. \nCredit Designation Statement: \nThe University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. The University of Wisconsin–Madison ICEP\, as a member of the University Professional & Continuing Education Association (UPCEA)\, authorizes this program for 0.1 CEUs or 1.0 hour.
URL:https://www.psychiatry.wisc.edu/event/conor-liston-md-phd-psychiatry-grand-rounds/
LOCATION:Webex
CATEGORIES:CME,Grand Rounds
ATTACH;FMTTYPE=image/jpeg:https://www.psychiatry.wisc.edu/wp-content/uploads/2019/02/Liston.jpeg
ORGANIZER;CN="Jennifer Noll":MAILTO:jnoll3@wisc.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20190220T120000
DTEND;TZID=America/Chicago:20190220T130000
DTSTAMP:20260619T181358
CREATED:20181004T180321Z
LAST-MODIFIED:20190220T215024Z
UID:3308-1550664000-1550667600@www.psychiatry.wisc.edu
SUMMARY:Educational Conference: Ronni Hayon\, MD - The "T" in LGBTQ: Providing Compassionate and Appropriate Care to TNG Patients
DESCRIPTION:2/20/19\nRonni Hayon\, MD  \nThe “T” in LGBTQ: Providing Compassionate and Appropriate Care to TNG Patients \n\nLearning Objectives:\n\n\n\n\nExploration of transphobia and privilege\nDiscuss key topics in medical and behavioral health as they relate to the care  of TNG people\nDevelop concrete skills for providing affirming care to TNG people\n\n\n\nRonni Hayon\, MD joined the Department of Family Medicine as an Assistant Professor in October 2012.  She received her medical degree from Drexel University College of Medicine in Philadelphia and she completed her Family Medicine residency at the UW-Madison Family Medicine Residency Program. Following residency\, Dr. Hayon completed a one-year Academic Fellowship with the Department of Family Medicine.  Dr. Hayon has lectured extensively regionally and nationally about LGBTQ health issues\, with a particular focus on transgender wellness. \n\nThe Educational Conference series is a series of lectures designed to provide clinically useful information to the practicing psychiatrist (faculty or trainee).  Every 1 to 2 months an intra- or extra-departmental speaker is invited to speak on a topic of interest selected by current faculty.  This educational series is open to the public and anyone is welcome to attend.  Continue Medical Education units (CME’s) are available to eligible attendees. \nLocation:\nGroup Room A\nUW Behavioral Health & Recovery\n1102 South Park Street\nMadison\, WI 53715 \n\n\nAccreditation Statement: \nIn support of improving patient care\, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. \nCredit Designation Statement: \nThe University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. The University of Wisconsin–Madison ICEP\, as a member of the University Professional & Continuing Education Association (UPCEA)\, authorizes this program for 0.1 CEUs or 1.0 hour.
URL:https://www.psychiatry.wisc.edu/event/educational-conference-ronni-hayon-md-care-of-the-transgender-patient/
LOCATION:Group Room A (4th Floor) | 1102 S Park St | UW Behavioral Health & Recovery\, 1102 S Park Street\, Suite 400\, Madison\, Wisconsin\, 53715
CATEGORIES:CME,Educational Conference (Park Street)
END:VEVENT
END:VCALENDAR